Document is current
Any future updates will be listed below
-
Authors
Menon, Poornima Jayadev https://orcid.org/0000-0003-0739-3313
Sambin, Sara
Criniere-Boizet, Baptiste
Courtin, Thomas
Tesson, Christelle
Casse, Fanny
Ferrien, Melanie
Mariani, Louise-Laure
Carvalho, Stephanie
Lejeune, Francois-Xavier
Rebbah, Sana
Martet, Gaspard
Houot, Marion
Lanore, Aymeric
Mangone, Graziella https://orcid.org/0000-0002-2847-3067
Roze, Emmanuel
Vidailhet, Marie
Aasly, Jan
Gan Or, Ziv https://orcid.org/0000-0003-0332-234X
Yu, Eric https://orcid.org/0000-0003-3525-4564
Dauvilliers, Yves
Zimprich, Alexander
Tomantschger, Volker
Pirker, Walter
Álvarez, Ignacio https://orcid.org/0000-0002-8537-3935
Pastor, Pau https://orcid.org/0000-0002-7493-8777
Di Fonzo, Alessio https://orcid.org/0000-0001-6478-026X
Bhatia, Kailash P.
Magrinelli, Francesca https://orcid.org/0000-0003-4706-6245
Houlden, Henry https://orcid.org/0000-0002-2866-7777
Real, Raquel https://orcid.org/0000-0001-8117-742X
Quattrone, Andrea https://orcid.org/0000-0003-2071-2083
Limousin, Patricia
Korlipara, Prasad
Foltynie, Thomas https://orcid.org/0000-0003-0752-1813
Grosset, Donald
Williams, Nigel
Narendra, Derek https://orcid.org/0000-0002-8696-9108
Lin, Hsin-Pin https://orcid.org/0000-0001-5320-2579
Jovanovic, Carna
Svetel, Marina
Lynch, Timothy
Gallagher, Amy https://orcid.org/0000-0003-2068-5628
Vandenberghe, Wim https://orcid.org/0000-0002-9758-5062
Gasser, Thomas https://orcid.org/0000-0002-1069-1146
Brockmann, Kathrin https://orcid.org/0000-0002-7515-8596
Morris, Huw R. https://orcid.org/0000-0002-5473-3774
Borsche, Max https://orcid.org/0000-0002-9651-5986
Klein, Christine https://orcid.org/0000-0003-2102-3431
Corti, Olga https://orcid.org/0000-0003-2093-7389
Brice, Alexis
Lesage, Suzanne
Corvol, Jean Christophe https://orcid.org/0000-0001-7325-0199
,
- License Information
-
More Information
Article History
Received: 26 June 2023
Accepted: 7 March 2024
First Online: 29 March 2024
Competing interests
: A.D.F. received honoraria for participating as scientifica board member to advisory board from Sanofi, Bial, Zambon. H.M. is employed by UCL. In the last 12 months he reports paid consultancy from Roche, Aprinoia and Amylyx; lecture fees/honoraria—BMJ, Kyowa Kirin, Movement Disorders Society. Research Grants from Parkinson’s UK, Cure Parkinson’s Trust, PSP Association, Medical Research Council, Michael J Fox Foundation. H.W.M. is a co-applicant on a patent application related to C9ORF72—Method for diagnosing a neurodegenerative disease (PCT/GB2012/052140). Z.G. Or received consultancy fees from Lysosomal Therapeutics Inc. (LTI), Idorsia, Prevail Therapeutics, Inceptions Sciences (now Ventus), Ono Therapeutics, Bial Biotech, Bial, Handl Therapeutics, UCB, Capsida, Denali Lighthouse, Guidepoint and Deerfield. E.R. was supported by Société Française de Médecine esthétique and Enjoysharing for his work on Parkinson disease. Jean-Christophe Corvol has served in advisory boards for Alzprotect, Bayer, Biogen, Denali, Ferrer, Idorsia, Prevail Therapeutic, Servier, Theranexus, UCB; and received grants from Sanofi. Kailash P. Bhatia has received grant support from Wellcome/MRC, NIHR, Parkinson’s UK and EU Horizon 2020. He receives royalties from the publication of the Oxford Specialist Handbook Parkinson’s Disease and Other Movement Disorders (Oxford University Press, 2008), of Marsden’s Book of Movement Disorders (Oxford University Press, 2012), and of Case Studies in Movement Disorders—Common and uncommon presentations (Cambridge University Press, 2017). He has received honoraria/personal compensation for participating as consultant/scientific board member from Ipsen, Allergan, Merz and honoraria for speaking at meetings and from Allergan, Ipsen, Merz, Sun Pharma, Teva, UCB Pharmaceuticals and from the American Academy of Neurology and the International Parkinson’s Disease and Movement Disorders Society. H.H. is grateful for the essential support from patients and families and for grateful funding from The Wellcome Trust, The MRC, The MSA Trust, The National Institute for Health Research University College London Hospitals Biomedical Research Centre, The Michael J Fox Foundation (MJFF), BBSRC, The Fidelity Trust, Rosetrees Trust, Ataxia UK, Brain Research UK, Sparks GOSH Charity, Alzheimer’s Research UK (ARUK) and CureDRPLA. D.N. has a research collaboration with Spark Therapeutics for which he receives research funding support. M.B. received honoraria from Ipsen Pharma. L.-L.M. has received research support grants from INSERM, JNLF, The L’Oreal Foundation, the French Parkinson Association, Fondation of France, Paris Brain Institute BBT and Neurocatalyst calls; speech honoraria from CSL, Sanofi-Genzyme, Lundbeck, Teva; consultant for Accure therapeutics, Sanofi and received travel funding from the Movement Disorders Society, ANAINF, Merck, Merz, Medtronic, Teva and AbbVie, outside the submitted work. All other authors declare no financial or non-financial competing interest.
